3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine

Catalog No. :
ACZYAQ563
CAS No. :
50-48-6
Molecular Formula :
C20H23N
Molecular Weight :
277.41

IUPAC Name:3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine

3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine
IUPAC Name3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine
Molecular FormulaC20H23N
Molecular Weight277.41
SMILESCN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
InChI KeyKRMDCWKBEZIMAB-UHFFFAOYSA-N
SynonymRedomex | Triptisol | Damilen | Lantron | Amitriptilina | amitriptyline | Amitryptiline | Triptanol | Elavil | Seroten | Adepril | Adepress | Flavyl | Amitriptylin | Laroxyl | Triptilin | Damitriptyline | Tryptanol | Amitriprolidine | Amytriptylin | Ro415
CAS No.50-48-6
PubChem CID2160

Synthetic Route by SureRoute

1. ACZYAQ563 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  6. Then
  7. ACZYAQ563 route product structure diagram
    ACZYAQ56350-48-6
Inquiry

2. ACZYAQ563 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACZYAQ563 route product structure diagram
    ACZYAQ56350-48-6
Inquiry

Comments (0)